Published in J Virol on December 01, 1989
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J Virol (1991) 3.62
Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J Virol (1992) 3.54
Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol Cell Biol (1994) 2.70
Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked proteins: toward establishing rules governing the lateral mobility of membrane proteins. J Cell Biol (1991) 2.28
The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1998) 1.99
GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J Cell Biol (1993) 1.78
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol (1994) 1.69
Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J Virol (1995) 1.59
Cell fusion activity of hepatitis C virus envelope proteins. J Virol (2000) 1.50
Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J Virol (1993) 1.47
A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. J Virol (1990) 1.37
Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line. J Virol (1999) 1.25
Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J Virol (1993) 1.25
Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains. J Virol (1993) 1.22
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol (1995) 1.20
Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol (2001) 1.19
Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J Virol (1995) 1.19
Effects of deletions in the carboxy-terminal hydrophobic region of herpes simplex virus glycoprotein gB on intracellular transport and membrane anchoring. J Virol (1993) 1.11
Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses. J Virol (1998) 1.02
Dissociation and reassociation of oligomeric viral glycoprotein subunits in the endoplasmic reticulum. J Virol (1991) 1.00
Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J Virol (1993) 0.98
Defective assembly and intracellular transport of mutant paramyxovirus hemagglutinin-neuraminidase proteins containing altered cytoplasmic domains. J Virol (1990) 0.98
Characterization of an endoplasmic reticulum retention signal in the rubella virus E1 glycoprotein. J Virol (1997) 0.97
Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1. Clin Exp Immunol (2001) 0.92
The lateral mobility of some membrane proteins is determined by their ectodomains. Biophys J (1992) 0.90
Effects of mutations in the rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity. J Virol (1998) 0.86
Construction and characterization of secreted and chimeric transmembrane forms of Drosophila acetylcholinesterase: a large truncation of the C-terminal signal peptide does not eliminate glycoinositol phospholipid anchoring. Mol Biol Cell (1996) 0.85
The establishment of polarized membrane traffic in Xenopus laevis embryos. J Cell Biol (1992) 0.80
GPI-anchored diphtheria toxin receptor allows membrane translocation of the toxin without detectable ion channel activity. EMBO J (1996) 0.80
Lack of glycosyl-phosphatidylinositol anchoring leads to precursor retention by a unique mechanism in Dictyostelium discoideum. Biochem J (1995) 0.80
Formation of heterotrimers between the membrane-integrated and the soluble glycoproteins of vesicular stomatitis virus leads to their intracellular cotransport. J Virol (1992) 0.77
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem (1985) 26.05
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus. J Biol Chem (1974) 8.13
Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol (1981) 7.97
Synchronised transmembrane insertion and glycosylation of a nascent membrane protein. Nature (1977) 7.72
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem (1988) 7.57
Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell (1986) 5.19
Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell (1983) 5.02
The rate of bulk flow from the endoplasmic reticulum to the cell surface. Cell (1987) 4.82
Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells. Cell (1982) 4.74
Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol (1988) 4.53
Compartmental organization of the Golgi stack. Cell (1985) 4.02
Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers. J Cell Biol (1987) 3.84
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81
Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein. Nature (1982) 3.74
Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein. J Cell Biol (1988) 3.10
A glycophospholipid tail at the carboxyl terminus of the Thy-1 glycoprotein of neurons and thymocytes. Science (1985) 3.05
Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein. Nature (1985) 2.97
Rapid processing of the carboxyl terminus of a trypanosome variant surface glycoprotein. Proc Natl Acad Sci U S A (1985) 2.67
Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science (1987) 2.59
Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding. J Biol Chem (1988) 2.30
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol (1983) 2.14
Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J (1984) 2.10
A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH. Science (1984) 2.07
Cytoplasmic domains of cellular and viral integral membrane proteins substitute for the cytoplasmic domain of the vesicular stomatitis virus glycoprotein in transport to the plasma membrane. J Cell Biol (1986) 1.88
Structure of the murine Thy-1 gene. EMBO J (1985) 1.69
Secretory protein targeting in a pituitary cell line: differential transport of foreign secretory proteins to distinct secretory pathways. J Cell Biol (1985) 1.62
Glycolipid anchors are attached to Thy-1 glycoprotein rapidly after translation. Biochem J (1987) 1.23
Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA. Proc Natl Acad Sci U S A (1988) 1.13
The glycophospholipid anchor of Thy-1. Biosynthetic labeling experiments with wild-type and class E Thy-1 negative lymphomas. J Biol Chem (1987) 1.00
Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell (1992) 17.81
Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A (1995) 9.08
Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol (1981) 7.97
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell (1981) 5.38
Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32
Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell (1983) 5.02
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell (2001) 4.79
Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells. Cell (1982) 4.74
Folding and assembly of viral membrane proteins. Virology (1993) 4.63
Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A (1978) 4.59
Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins. J Virol (1981) 4.49
Tryptophan messenger ribonucleic acid elongation rates and steady-state levels of tryptophan operon enzymes under various growth conditions. J Mol Biol (1970) 3.89
The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol (1996) 3.89
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol (1993) 3.73
Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science (1989) 3.59
Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science (1985) 3.54
Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A (1996) 3.54
Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell (1997) 3.47
Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell (1997) 3.46
Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem (1975) 3.44
Structure of the AAA ATPase p97. Mol Cell (2000) 3.37
The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell (1989) 3.24
Translation of individual species of vesicular stomatitis viral mRNA. J Virol (1975) 3.12
Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein. J Cell Biol (1988) 3.10
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07
Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol (1999) 3.04
5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature (1977) 3.00
A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region. J Cell Biol (1987) 2.97
CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol (1990) 2.96
Limitations of he Dixon plot for ascertaining naure of enzyme inhibition. Tex Rep Biol Med (1969) 2.91
Fitness to drive and the older patient: awareness among hospital physicians. Lancet (1994) 2.91
The presence of cysteine in the cytoplasmic domain of the vesicular stomatitis virus glycoprotein is required for palmitate addition. Proc Natl Acad Sci U S A (1984) 2.91
Vesicular stomatitis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain near the COOH terminus. Proc Natl Acad Sci U S A (1980) 2.87
Nucleotide sequence complexities, molecular weights, and poly(A) content of the vesicular stomatitis virus mRNA species. J Virol (1975) 2.85
Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature (1976) 2.81
A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol (1985) 2.78
Structural requirements of a membrane-spanning domain for protein anchoring and cell surface transport. Cell (1985) 2.76
Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol Cell Biol (1994) 2.70
A single amino acid substitution in a hydrophobic domain causes temperature-sensitive cell-surface transport of a mutant viral glycoprotein. J Virol (1985) 2.68
Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J (1998) 2.64
Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity. Cell (1989) 2.58
Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. J Biol Chem (1990) 2.56
Membrane association of functional vesicular stomatitis virus matrix protein in vivo. J Virol (1993) 2.56
Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J Virol (1993) 2.54
Conversion of a secretory protein into a transmembrane protein results in its transport to the Golgi complex but not to the cell surface. Cell (1984) 2.49
Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol (1997) 2.48
Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature (1990) 2.48
Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1980) 2.46
Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity (1995) 2.39
Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol (1993) 2.38
Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding. J Biol Chem (1988) 2.30
Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci U S A (1998) 2.29
Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked proteins: toward establishing rules governing the lateral mobility of membrane proteins. J Cell Biol (1991) 2.28
Regulation of in vitro transcription of the tryptophan operon by purified RNA polymerase in the presence of partially purified repressor and tryptophan. Nat New Biol (1973) 2.20
Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J Cell Biol (1996) 2.19
Nucleotide sequence of a cDNA clone encoding the entire glycoprotein from the New Jersey serotype of vesicular stomatitis virus. J Virol (1983) 2.19
Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol (1983) 2.14
Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell (1994) 2.08
High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol (1997) 2.07
A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH. Science (1984) 2.07
Glycosylation allows cell-surface transport of an anchored secretory protein. Cell (1985) 2.06
Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase. Mol Cell Biol (1990) 2.06
Nucleotide sequences of ribosome recgonition sites in messenger RNAs of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 2.05
Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology (1999) 2.03
Prescribing limitations. Br Dent J (2001) 2.03
Interaction of the operator of the tryptophan operon with repressor. Proc Natl Acad Sci U S A (1974) 2.02
N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol (1986) 2.01
Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem (1985) 1.99
Complete sequences of the ribosome recognition sites in vesicular stomatitis virus mRNAs: recognition by the 40S and 80S complexes. Cell (1978) 1.97
Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J Virol (1994) 1.93
Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg (1997) 1.91
Metabolic regulation of the tryptophan operon of Escherichia coli: repressor-independent regulation of transcription initiation frequency. J Mol Biol (1972) 1.89
Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. Eur J Biochem (1986) 1.89
Cytoplasmic domains of cellular and viral integral membrane proteins substitute for the cytoplasmic domain of the vesicular stomatitis virus glycoprotein in transport to the plasma membrane. J Cell Biol (1986) 1.88
Dilemmas of "informed consent" in children. N Engl J Med (1973) 1.87
Sphygmomanometers: errors due to blocked vents. Br Med J (1979) 1.86
Temperature-dependent expression of flagella of Listeria monocytogenes studied by electron microscopy, SDS-PAGE and western blotting. J Gen Microbiol (1988) 1.85
Relative importance of 7-methylguanosine in ribosome binding and translation of vesicular stomatitis virus mRNA in wheat germ and reticulocyte cell-free systems. J Biol Chem (1977) 1.85
Evidence for the loop model of signal-sequence insertion into the endoplasmic reticulum. Proc Natl Acad Sci U S A (1988) 1.84
Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomocysteine. J Virol (1977) 1.80
The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex. Proc Natl Acad Sci U S A (1990) 1.79
Incorporation of a charged amino acid into the membrane-spanning domain blocks cell surface transport but not membrane anchoring of a viral glycoprotein. Mol Cell Biol (1985) 1.79
Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology (1991) 1.77
Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology (1998) 1.75
Monoclonal antibodies reactive with hairy cell leukemia. Blood (1989) 1.75
Sedation for oocyte retrieval using target controlled infusion of propofol and incremental alfentanil delivered by non-anaesthetists. Anaesthesia (2010) 1.74
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol (2000) 1.74
Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol (1997) 1.72
5'-terminus of Moloney murine leukemia virus 35s RNA is m7G5' ppp5' GmpCp. J Virol (1976) 1.70
A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain. Clin Radiol (2007) 1.70
Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids. J Virol (1994) 1.68
Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology (2001) 1.68
GPs' experiences of primary care mental health research: a qualitative study of the barriers to recruitment. Fam Pract (2007) 1.64
Nucleotide sequences from the 3'-ends of vesicular stomatitis virus mRNA's as determined from cloned DNA. J Virol (1979) 1.64
Postnatal development of the cutaneous flexor reflex: comparative study of preterm infants and newborn rat pups. Dev Med Child Neurol (1988) 1.64